Insider Transactions in Q2 2025 at Oncology Institute, Inc. (TOI)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2025
|
Richard A Barasch Director |
BUY
Conversion of derivative security
|
Indirect |
620,400
+19.53%
|
-
|
|
Jun 17
2025
|
Richard A Barasch Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
311,128
-9.62%
|
$622,256
$2.62 P/Share
|
|
Jun 17
2025
|
Richard A Barasch Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
679,224
+17.35%
|
$679,224
$1.2 P/Share
|
|
Jun 17
2025
|
Richard A Barasch Director |
BUY
Conversion of derivative security
|
Direct |
159,500
+7.61%
|
-
|
|
Jun 05
2025
|
M33 Growth I L.P. Director |
SELL
Open market or private sale
|
Indirect |
76,324
-5.66%
|
$228,972
$3.05 P/Share
|
|
Jun 05
2025
|
M33 Growth I L.P. Director |
SELL
Open market or private sale
|
Direct |
673,676
-4.61%
|
$2,021,028
$3.05 P/Share
|
|
Jun 03
2025
|
Brad Hively Director |
SELL
Open market or private sale
|
Direct |
1,976,137
-43.82%
|
$3,952,274
$2.87 P/Share
|
|
Jun 03
2025
|
Brad Hively Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,867,605
+18.43%
|
$1,867,605
$1.01 P/Share
|
|
May 21
2025
|
Jeffrey Langsam Chief Clinical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,380
+50.0%
|
-
|
|
May 21
2025
|
Daniel Virnich Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,388
-1.13%
|
$40,776
$2.67 P/Share
|
|
May 21
2025
|
Yale Podnos Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,801
-0.76%
|
$3,602
$2.67 P/Share
|
|
May 21
2025
|
Robert Ross Carter Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,601
-0.68%
|
$3,202
$2.67 P/Share
|
|
May 21
2025
|
Jeremy Castle Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,636
-2.23%
|
$11,272
$2.67 P/Share
|
|
May 20
2025
|
M33 Growth I L.P. Director |
SELL
Open market or private sale
|
Indirect |
203,532
-13.11%
|
$407,064
$2.71 P/Share
|
|
May 20
2025
|
M33 Growth I L.P. Director |
SELL
Open market or private sale
|
Direct |
1,796,468
-10.94%
|
$3,592,936
$2.71 P/Share
|